Our previous studies showed that ceramide can restore wt p53 expression and functional activity in ovarian cancer OVCAR-8 and NCI/ADR-RES cells that carry p53 deletion mutations in codons 126-132 and 126-133, respectively [32, 33]. Here, TP53 is linked to ovarian carcinoma.